Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $237,799 - $324,029
7,882 Added 51.11%
23,305 $842,000
Q4 2022

Feb 14, 2023

SELL
$36.43 - $49.4 $1.81 Million - $2.45 Million
-49,614 Reduced 76.29%
15,423 $610,000
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $1.02 Million - $1.33 Million
-25,057 Reduced 27.81%
65,037 $3.03 Million
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $2.21 Million - $4.21 Million
54,219 Added 151.13%
90,094 $3.95 Million
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $1.11 Million - $1.71 Million
-18,544 Reduced 34.08%
35,875 $2.6 Million
Q4 2021

Feb 14, 2022

SELL
$81.07 - $121.29 $8.81 Million - $13.2 Million
-108,723 Reduced 66.64%
54,419 $4.41 Million
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $8.97 Million - $14.6 Million
-87,971 Reduced 35.03%
163,142 $19 Million
Q2 2021

Aug 16, 2021

SELL
$141.6 - $179.06 $411,206 - $519,990
-2,904 Reduced 1.14%
251,113 $41.6 Million
Q1 2021

May 17, 2021

BUY
$132.81 - $182.18 $10.2 Million - $14 Million
76,577 Added 43.16%
254,017 $35.4 Million
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $16.8 Million - $22.4 Million
-121,712 Reduced 40.69%
177,440 $30.7 Million
Q3 2020

Nov 16, 2020

SELL
$114.09 - $145.51 $2.62 Million - $3.34 Million
-22,979 Reduced 7.13%
299,152 $41.7 Million
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $12.8 Million - $18.6 Million
143,469 Added 80.3%
322,131 $38.5 Million
Q1 2020

May 15, 2020

BUY
$70.23 - $144.31 $12.5 Million - $25.8 Million
178,662 New
178,662 $17.9 Million
Q4 2018

Feb 14, 2019

SELL
$35.43 - $56.29 $407,126 - $646,828
-11,491 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$44.22 - $75.47 $335,629 - $572,817
7,590 Added 194.57%
11,491 $655,000
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $282,354 - $360,842
3,901 New
3,901 $311,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.